Clinical Trial

Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the impact of herpes zoster vaccine on the incidence of herpes zoster and survival in lung cancer patients, and to explore its preventive effect and safety.
Trial Details
NCT Number NCT07170059
Lead Sponsor The First Affiliated Hospital of Guangzhou Medical University
Conditions Lung Cancer
Enrollment 500 participants
Start Date 2025-10-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2030-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-12